We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOO:NASDAQBRP Inc. Analysis

Data as of 2026-08-22 - not real-time

$68.04

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind BRP Inc. is neutral at $68.04, with no clear ordering between short and long averages. It has gained 15.2% over the past 30 days. With RSI at 63.3 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near $59.82 and resistance around $70.11.
On valuation the read is overvalued — an earnings multiple of 22.5, absent a reliable peer benchmark. The average analyst target implies 5.6% above today's level. Revenue is growing at 29.5% on a 3.0% profit margin. The 1.03% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 33.4%, a beta of 0.88 and a maximum drawdown of 37.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

Updated Tue, August 18, 2026 at 11:33 AM UTC 0 - New Can-Am Defender XU model brings factory-installed utility-focused...Updated Jul 6, 2026 0 The Company is highlighting its commitment to the local community with a $75,000 donation to...BRP Inc. TSX: DOO NASDAQ: DOO stands out once again on the international stage with four Red Dot Awards, including a...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 66.40
  • MACD momentum is positive
  • 30-day price change of +15.2%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 66.40
  • Analyst targets imply +5.6% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +5.6% versus the current price
  • Revenue growth of +29.5%
  • P/E ratio of 22.5

Key Metrics & Analysis

Financial Health

Revenue Growth29.50%
Profit Margin3.01%
P/E Ratio22.5
ROE52.33%
ROA7.19%
Debt/Equity415.87
P/B Ratio10.0
Op. Cash Flow$1.4B
Free Cash Flow$899.2M

Technical Analysis

TrendNeutral
RSI63.3
Support$59.82
Resistance$70.11
MA 20$64.40
MA 50$61.76
MA 200$66.40
MACDBullish
VolumeStable
Fear & Greed Index94.41

Valuation

Fair Value$397.80
Target Price$71.86
Upside/Downside5.61%
GradeOvervalued
TypeGrowth
Dividend Yield1.03%

Risk Assessment

Beta0.88
Volatility33.38%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.